Rebyota is a fecal microbiota live-jslm product approved by the FDA for preventing recurrent C. diff infection in the form of a single 150 mL dose administered rectally. Data from more than 1,500 ...

Cases of a potentially killer infection that can spread rampantly in hospitals have surged by a third in a year, health officials have warned. Clostridioides difficile, commonly referred to as C.

RBX2660 has been granted Orphan Drug status, Fast Track status and gained Breakthrough Therapy Designation from the FDA in October 2015 for its potential to prevent recurrent C. diff. infection.

SAN DIEGO — Administration of Rebyota by colonoscopy appears safe and effective among adults with recurrent Clostridioides difficile infection ... data for recurrent C. diff patients receiving ...

The pharma company was quick to point out however that the CLOVER trial of PF-06425090 was undermined by a lower-than expected rate of C. diff infection (CDI) as a result of social isolation ...

Mild Clostridium difficile infection (CDI; stool frequency <four-times daily; no signs of severe colitis), clearly induced by the use of antibiotics, may be treated by stopping the inducing ...

Hand sanitizer is great to have when you absolutely can't wash your hands, but you shouldn't depend on it, given its inability to kill certain bacteria or viruses such as C. diff and norovirus ...

Hand sanitizer is great to have when you absolutely can’t wash your hands, but you shouldn’t depend on it, given its inability to kill certain bacteria or viruses such as C. diff and norovirus ...